Editorial Board
Shulin Li
The University of Texas MD Anderson Cancer Center, Houston, Texas · United States
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Immune Therapy
- Gene Therapy
- Circulating Tumor Cells
Biography
- 1993 PhD Washington State University
- 2010 Professor of MD Anderson Cancer Center
Selected publications
- Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme 2021 cited 111×
- WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression 2021 cited 50×
- Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models 2024 cited 33×
- FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells 2023 cited 28×
- Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile 2019 cited 19×
- Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma 2022 cited 15×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Shulin Li (The University of Texas MD Anderson Cancer Center, Houston, Texas) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.